Avanos Medical (NYSE:AVNS) announced today that it appointed David Pacitti as its new CEO, effective April 14, 2025.
Medical announced the appointment of David Pacitti as its new CEO, effective April 14. Pacitti joins Avanos with a distinguished ...
Zacks Investment Research on MSN11h
New Strong Sell Stocks for March 18th
List today: Avanos Medical AVNS is a medical technology company which offers infection prevention, surgical, respiratory, digestive health and pain management solutions. The Zacks Consensus Estimate ...
Siemens Healthineers’ president of the Americas, David Pacitti, is leaving the imaging giant to become CEO of the devicemaker ...
Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.
An update from Avanos Medical ( ($AVNS) ) is now available. On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its ...
Avanos Medical named David Pacitti as its next chief executive officer, effective April 14. The medical technology company will pay Pacitti a base salary around $1.1 million and he would be eligible ...
Highlights,Avanos Medical operates in the medical technology sector, specializing in advanced healthcare ...
Highlights,Avanos Medical’s stock recently witnessed a shift in analyst ratings from "buy" to "hold".,Institutional investors ...
Investors in Avanos Medical, Inc. AVNS need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2025 $10.00 Call had some of the highest ...
ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Avanos Medical, Inc. (AVNS) on Wednesday reported a fourth-quarter loss of $397.3 million, after reporting a profit in the same period a year earlier.